Icon

Zomig - (5 mg/Spray, Spary, Nasal)

Zolmitriptan Astrazeneca
5 mg/Spray, Spary, Nasal
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
Used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms
Yes
******* ** *** ***** ** **** **** ** **** ******* '*** (*** *, ****), '*** (*** *, ****) *** ***** *** ***** *****. ** ****** **** **** ******* ******* ** *** **** **** ** ******* ** * ********** *** ** ******** ****. ****** *** ***** ***** *******, *** ***** **** ** **** ****** '*** *** *.*** *** *** ***** *****. **** ******* ** *** *** *** *** ***** ***** ***** *** *** *** *.* ** ***** ***** *****. ** ****** **** **** *** ******* ** ***** ****. ** *** ****** ** ***** *** **** *** ********* ** ****, ******* ** *** **** ** ******* ** *******. ******* **** *** **** ******* ***** ** *** (*** *, ****), '*** (*** *, ****) *******. **** ********* ******* ****** *** **** ***** *** ** ********.
Zomig Patent 1 Patent 2
******* **** ** ** **** ** **
*** ****** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* *** \ ** *** **, **** **** ** ** **** ****** **** ********
*** ****** ** \ ** ***** **, **** ******* **** ****** **** ********
  1. *** **, **** : ******* ******** ***** ***** *** **** ** **** ***** * ** ***** **** ******* '*** (*** *, ****), '*** (*** *, ****).
  2. *** **, **** : ***** ***** * **** ******* ******* ** ******** ***** ** ********.
  3. *** **, **** : *** ******** ***** ***** *** **** ** *** ***** *.*,*** ***** **** ****** '*** (*** *, ****)
  4. *** **, **** : ***** ***** * **** ******* *** ** ******** ***** ** ********.
  5. *** **, **** : ******* ****** ** ***** **** '*** (*** *, ****), '*** (*** *, ****) ******* *** *******.
  6. *** *, **** : ********** ********* **** *** ******
  7. *** **, **** : ******* ***** ******* ******** *****'* ********

Zomig - (2.5 mg/spray)

Zolmitriptan Astrazeneca
2.5 mg/spray
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
None
Less Than 5
Less Than 5
None
No
*** ***** **** ** **** ****** '*** *** *.*** ***** *****. **** *** ** *** *** *** *.*** ***** ***** *****. ** ****** **** **** *** ******* ** ***** ****. *****, ********** ********* **** *** ******
Zomig Patent 1 Patent 2
*** ****** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
*** ****** *** \ ** ***** **, **** ******* **** ****** **** ********
  1. *** **, **** : *** ******** ***** ***** *** **** ** *** ***** *.* ***** **** ****** '*** (*** *, ****)
  2. *** **, **** : ***** ***** * **** ******* *** ** ******** ***** ** ********.
  3. *** *, **** : ********** ********* **** *** ******

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.